OncoScint Mab
Company
Cytogen Corporation
Use
Serves as a antibody based radiolabeling agent that detects colorectal and ovarian cancer
Features
Offers a less expensive alternative to PET scans and more widely available
NIH Contribution
Produced the antibodies that are reactive with human breast cancer
HHS Institute/Agency
NCI
Inventor(s)
J. Schlom, C. Austin, D. Colcher, P. Hand, M. Nuti
Year
1994
Tech Cat
Diagnostic
